Search

Author/Creator McKeage, Mark J.

4. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics. (1st December 2016)

Authors:
Han, Catherine H.; Kilfoyle, Dean H.; Hill, Andrew G.; Jameson, Michael B.; McKeage, Mark J.
Journal:
Expert opinion on drug metabolism and toxicology
Issue:
Volume 12:Number 12(2016:Dec.)
Page Start:
1479
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand. Issue 6 (14th June 2020)

Authors:
McKeage, Mark J.; Tin Tin, Sandar; Khwaounjoo, Prashannata; Sheath, Karen; Dixon‐McIver, Amanda; Ng, Daniel; Sullivan, Richard; Cameron, Laird; Shepherd, Philip; Laking, George R.; Kingston, Nicola; Strauss, Magreet; Lewis, Christopher; Elwood, Mark; Love, Donald R.
Journal:
Internal medicine journal
Issue:
Volume 50:Issue 6(2020)
Page Start:
716
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗